{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:56:06Z","timestamp":1790812566064,"version":"4.1.0"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Acute otitis media is a leading cause of childhood morbidity and antibiotic prescriptions. We examined etiologic changes in acute otitis media after introduction of 13-valent pneumococcal conjugate vaccine as routine immunization for Japanese children in 2014. Serotypes, resistance genotypes, antibiotic susceptibilities and multilocus sequence typing of pneumococcal isolates were also characterized.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Otolaryngologists prospectively collected middle ear fluid from 582 children by tympanocentesis or sampling through a spontaneously ruptured tympanic membrane between June 2016 and January 2017. Causative pathogens were identified by bacterial culture and real-time polymerase chain reaction for bacteria. Serotypes, resistance genotypes, sequence types and susceptibilities to 14 antimicrobial agents were determined for pneumococcal isolates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>At least 1 bacterial pathogen was identified in 473 of the samples (81.3%). Nontypeable<jats:italic toggle=\"yes\">Haemophilus influenzae<\/jats:italic>(54.8%) was detected most frequently, followed by<jats:italic toggle=\"yes\">Streptococcus pneumoniae<\/jats:italic>(25.4%),<jats:italic toggle=\"yes\">Streptococcus pyogenes<\/jats:italic>(2.9%) and others. Pneumococci of current vaccine serotypes have decreased dramatically from 82.1% in 2006 to 18.5% (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt; 0.001). Commonest serotypes were 15A (14.8%), 3 (13.9%) and 35B (11.1%). Serotype 3 was significantly less frequent among children receiving 13-valent pneumococcal conjugate vaccine compared with 7-valent pneumococcal conjugate vaccine (<jats:italic toggle=\"yes\">P<\/jats:italic>= 0.002). Genotypic penicillin-resistant<jats:italic toggle=\"yes\">S. pneumoniae<\/jats:italic>accounted for 28.7%, slightly less than in 2006 (34.2%;<jats:italic toggle=\"yes\">P<\/jats:italic>= 0.393); the penicillin-resistant serotypes 15A and 35B had increased. Serotypes 15A, 3 and 35B most often belonged to sequence types 63, 180 and 558.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>Our findings are expected to assist in development of future vaccines, and they underscore the need for appropriate clinical choice of oral agents based on testing of causative pathogens.<\/jats:p><\/jats:sec>","DOI":"10.1097\/inf.0000000000001956","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T21:15:35Z","timestamp":1519420535000},"page":"598-604","source":"Crossref","is-referenced-by-count":51,"title":["Etiology of Acute Otitis Media and Characterization of Pneumococcal Isolates After Introduction of 13-Valent Pneumococcal Conjugate Vaccine in Japanese Children"],"prefix":"10.1097","volume":"37","author":[{"given":"Kimiko","family":"Ubukata","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Keio University, School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Morozumi","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Keio University, School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Sakuma","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Keio University, School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misako","family":"Takata","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Keio University, School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Mokuno","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Hakujikai Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tajima","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hakujikai Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Keio University, School of Medicine"},{"name":"Department of Infectious Diseases, National Cancer Center Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1473-3099(10)70012-8","article-title":"Otitis media and its consequences: beyond the earache.","volume":"10","author":"Vergison","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"e36226","DOI":"10.1371\/journal.pone.0036226","article-title":"Burden of disease caused by otitis media: systematic review and global estimates.","volume":"7","author":"Monasta","year":"2012","journal-title":"PLoS One"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1542\/peds.2012-3488","article-title":"The diagnosis and management of acute otitis media.","volume":"131","author":"Lieberthal","year":"2013","journal-title":"Pediatrics"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/archdischild-2013-305550","article-title":"The diagnosis and management of acute otitis media: American Academy of Pediatrics Guidelines 2013.","volume":"100","author":"Siddiq","year":"2015","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.ijporl.2010.08.016","article-title":"Acute otitis media: from diagnosis to prevention. Summary of the Italian guideline.","volume":"74","author":"Marchisio","year":"2010","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.anl.2014.09.006","article-title":"Clinical practice guidelines for the diagnosis and management of acute otitis media (AOM) in children in Japan - 2013 update.","volume":"42","author":"Kitamura","year":"2015","journal-title":"Auris Nasus Larynx"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1001\/jama.2010.1651","article-title":"Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review.","volume":"304","author":"Coker","year":"2010","journal-title":"JAMA"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"e0150949","DOI":"10.1371\/journal.pone.0150949","article-title":"Predominant bacteria detected from the middle ear fluid of children experiencing otitis media: a systematic review.","volume":"11","author":"Ngo","year":"2016","journal-title":"PLoS One"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/INF.0000000000001420","article-title":"Etiology of acute otitis media in children less than 5 years of age: a pooled analysis of 10 similarly designed observational studies.","volume":"36","author":"Van Dyke","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1086\/430605","article-title":"Acute otitis media caused by Streptococcus pyogenes in children.","volume":"41","author":"Segal","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/1471-2334-12-312","article-title":"Identification and characterization of the bacterial etiology of clinically problematic acute otitis media after tympanocentesis or spontaneous otorrhea in German children.","volume":"12","author":"Grevers","year":"2012","journal-title":"BMC Infect Dis"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00431-014-2409-0","article-title":"Bacterial spectrum of spontaneously ruptured otitis media in the era of pneumococcal conjugate vaccination in Germany.","volume":"174","author":"van der Linden","year":"2015","journal-title":"Eur J Pediatr"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/509332","article-title":"Microbiology of acute otitis media in children with tympanostomy tubes: prevalences of bacteria and viruses.","volume":"43","author":"Ruohola","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/00016480802032777","article-title":"Detection of respiratory viruses in nasopharyngeal secretions and middle ear fluid from children with acute otitis media.","volume":"129","author":"Yano","year":"2009","journal-title":"Acta Otolaryngol"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1469-0691.2010.03182.x","article-title":"Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period.","volume":"16","author":"Li\u00f1ares","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1016\/j.vaccine.2013.07.054","article-title":"Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations.","volume":"31","author":"Hackel","year":"2013","journal-title":"Vaccine"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"e93752","DOI":"10.1371\/journal.pone.0093752","article-title":"Molecular characterization and antimicrobial susceptibility of Streptococcus pneumoniae isolated from children hospitalized with respiratory infections in Suzhou, China.","volume":"9","author":"Geng","year":"2014","journal-title":"PLoS One"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"e68711","DOI":"10.1371\/journal.pone.0068711","article-title":"Incidence survey of acute otitis media in children in Sado Island, Japan\u2013Sado Otitis Media Study (SADOMS).","volume":"8","author":"Otsuka","year":"2013","journal-title":"PLoS One"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1128\/JCM.01782-08","article-title":"Serotype distribution and penicillin resistance of Streptococcus pneumoniae isolates from middle ear fluids of pediatric patients with acute otitis media in Japan.","volume":"46","author":"Hotomi","year":"2008","journal-title":"J Clin Microbiol"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200012283432603","article-title":"Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.","volume":"343","author":"Whitney","year":"2000","journal-title":"N Engl J Med"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1016\/j.vaccine.2017.06.049","article-title":"Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands.","volume":"35","author":"Vestjens","year":"2017","journal-title":"Vaccine"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"e89013","DOI":"10.1371\/journal.pone.0089013","article-title":"Pneumococcal aetiology and serotype distribution in paediatric community-acquired pneumonia.","volume":"9","author":"De Schutter","year":"2014","journal-title":"PLoS One"},{"key":"R23-20230912","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1016\/j.vaccine.2015.06.062","article-title":"Impact of PCV7\/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years.","volume":"33","author":"Greenberg","year":"2015","journal-title":"Vaccine"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"R25-20230912","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/INF.0b013e318275614b","article-title":"Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.","volume":"32","author":"Kaplan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R26-20230912","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"R27-20230912","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"R28-20230912","doi-asserted-by":"crossref","first-page":"6484","DOI":"10.1128\/AAC.03344-14","article-title":"Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States.","volume":"58","author":"Richter","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R29-20230912","doi-asserted-by":"crossref","first-page":"60. e9","DOI":"10.1016\/j.cmi.2015.08.027","article-title":"Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA.","volume":"22","author":"Metcalf","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"R30-20230912","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1016\/j.vaccine.2014.04.066","article-title":"European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era.","volume":"32","author":"Navarro Torn\u00e9","year":"2014","journal-title":"Vaccine"},{"key":"R31-20230912","article-title":"Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: insights from Israeli surveillance studies.","author":"Ben-Shimol","year":"2017","journal-title":"Vaccine"},{"key":"R32-20230912","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1016\/j.vaccine.2016.07.038","article-title":"Impact of PCV7\/PCV13 introduction on invasive pneumococcal disease (IPD) in young children: comparison between meningitis and non-meningitis IPD.","volume":"34","author":"Ben-Shimol","year":"2016","journal-title":"Vaccine"},{"key":"R33-20230912","doi-asserted-by":"crossref","first-page":"e54333","DOI":"10.1371\/journal.pone.0054333","article-title":"Dynamics of Streptococcus pneumoniae serotypes causing acute otitis media isolated from children with spontaneous middle-ear drainage over a 12-year period (1999-2010) in a region of northern Spain.","volume":"8","author":"Alonso","year":"2013","journal-title":"PLoS One"},{"key":"R34-20230912","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.vaccine.2017.02.010","article-title":"Pneumococcal carriage and serotype variation before and after introduction of pneumococcal conjugate vaccines in patients with acute otitis media in Switzerland.","volume":"35","author":"Allemann","year":"2017","journal-title":"Vaccine"},{"key":"R35-20230912","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s12879-016-1750-5","article-title":"Reduction of Streptococcus pneumoniae in upper respiratory tract cultures and a decreased incidence of related acute otitis media following introduction of childhood pneumococcal conjugate vaccines in a Swedish county.","volume":"16","author":"Littorin","year":"2016","journal-title":"BMC Infect Dis"},{"key":"R36-20230912","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/cid\/civ067","article-title":"Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era.","volume":"60","author":"Kaplan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R37-20230912","doi-asserted-by":"crossref","first-page":"e20174067","DOI":"10.1542\/peds.2017-0181","article-title":"Epidemiology of acute otitis media in the postpneumococcal conjugate vaccine era.","volume":"140","author":"Kaur","year":"2017","journal-title":"Pediatrics"},{"key":"R38-20230912","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/ciu683","article-title":"Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent\/13-valent PCV.","volume":"59","author":"Ben-Shimol","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R39-20230912","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/cid\/ciw347","article-title":"Impact of widespread introduction of pneumococcal conjugate vaccines on pneumococcal and nonpneumococcal otitis media.","volume":"63","author":"Ben-Shimol","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R40-20230912","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/INF.0000000000000387","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on chronic sinusitis associated with Streptococcus pneumoniae in children.","volume":"33","author":"Olarte","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R41-20230912","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/INF.0000000000001206","article-title":"Emerging Streptococcus pneumoniae strains colonizing the nasopharynx in children after 13-valent pneumococcal conjugate vaccination in comparison to the 7-valent era, 2006-2015.","volume":"35","author":"Kaur","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R42-20230912","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cmi.2014.08.009","article-title":"Decline in antibiotic resistance and changes in the serotype distribution of Streptococcus pneumoniae isolates from children with acute otitis media; a 2001-2011 survey by the French Pneumococcal Network.","volume":"21","author":"Kempf","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"R43-20230912","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1097\/INF.0000000000000445","article-title":"Emergence of Streptococcus pneumoniae serogroups 15 and 35 in nasopharyngeal cultures from young children with acute otitis media.","volume":"33","author":"Martin","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R44-20230912","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1128\/JCM.01778-16","article-title":"Emergence of multidrug-resistant pneumococcal serotype 35B among children in the United States.","volume":"55","author":"Olarte","year":"2017","journal-title":"J Clin Microbiol"},{"key":"R45-20230912","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3201\/eid2007.131485","article-title":"Changes in capsule and drug resistance of Pneumococci after introduction of PCV7, Japan, 2010-2013.","volume":"20","author":"Chiba","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"R46-20230912","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vaccine.2015.11.015","article-title":"Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.","volume":"34","author":"Nakano","year":"2016","journal-title":"Vaccine"},{"key":"R47-20230912","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3201\/eid2111.142029","article-title":"Serotype changes and drug resistance in invasive pneumococcal diseases in adults after vaccinations in children, Japan, 2010-2013.","volume":"21","author":"Ubukata","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"R48-20230912","first-page":"49","article-title":"Real-time PCR detection of causative microorganisms in pediatric patients with actute otitis media in clinical phase III tebipenem-pivoxil studies.","volume":"57","author":"Ubukata","year":"2009","journal-title":"Chemotherapy"},{"key":"R49-20230912","first-page":"58","article-title":"Antibiotic susceptibility and resistance gene analysis of Streptococcus pneumoniae in clinical tebipenem-pivoxil studies in pediatric patients using PCR method.","volume":"57","author":"Ubukata","year":"2009","journal-title":"Chemotherapy"},{"key":"R50-20230912","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/mdr.2011.0102","article-title":"Application of the real-time PCR method for genotypic identification of \u03b2-lactam resistance in isolates from invasive pneumococcal diseases.","volume":"18","author":"Chiba","year":"2012","journal-title":"Microb Drug Resist"},{"key":"R51-20230912","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1473-3099(15)00549-6","article-title":"Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease.","volume":"16","author":"Dagan","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"R52-20230912","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/528996","article-title":"Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.","volume":"197","author":"Moore","year":"2008","journal-title":"J Infect Dis"},{"key":"R53-20230912","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1086\/341072","article-title":"Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States.","volume":"186","author":"Beall","year":"2002","journal-title":"J Infect Dis"},{"key":"R54-20230912","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1097\/INF.0000000000000776","article-title":"Impact of the seven-valent pneumococcal conjugate vaccine on acute otitis media in Japanese children: emergence of serotype 15A multidrug-resistant Streptococcus pneumoniae in middle ear fluid isolates.","volume":"34","author":"Ozawa","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R55-20230912","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1128\/AAC.49.3.889-894.2005","article-title":"In vitro activity of tebipenem, a new oral carbapenem antibiotic, against penicillin-nonsusceptible Streptococcus pneumoniae.","volume":"49","author":"Kobayashi","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R56-20230912","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s10156-012-0500-x","article-title":"Antibiotic susceptibility in relation to genotype of Streptococcus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae responsible for community-acquired pneumonia in children.","volume":"19","author":"Morozumi","year":"2013","journal-title":"J Infect Chemother"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201806000-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:24:59Z","timestamp":1751415899000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201806000-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001956","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}